According to the latest report published by Credence Research, Inc. “Endometrial Ablation Devices Market – Growth, Future Prospects and Competitive Analysis, 2018-2026,” the global Endometrial Ablation market was valued at USD 985.8 Mn in 2017, and is expected to reach USD 1,588.3 Mn by 2026, expanding at a CAGR of 5.3% from 2018 to 2026.
Browse the full report Endometrial Ablation Devices Market – Growth, Future Prospects and Competitive Analysis, 2018-2026 report at https://www.credenceresearch.com/report/endometrial-ablation-devices-market
Endometrial ablation is considered the most effective minimally invasive procedure to treat abdominal uterine bleeding in some cases compared to hysterectomy or other medical treatments. It is efficiently replacing resectoscopic ablation technologies specifically for abdominal uterine bleeding. However, resectoscope is still essential for the treatment of sub-mucosal fibroids, adenomyoma, large polyps, and mullerian anomaly among others. There are some novel technologies that are expected to assist the market growth in the near future such as Minerva (Argon-bipolar technology), Cerene (Cryotherapy), Aegea (Low Pressure Vapor), and Lina Librata (Glycerine-filled Balloon). The key advantages possessed by endometrial ablation are a lower rate of serious side-effects, and post-surgery hospitalization. Endometrial ablation device market faces challenges such as low treatment access, lack of trained physicians, and noticeable failure rates.
Radiofrequency endometrial ablation devices accounted for the largest share of around 55% due to key market driving factors such as high safety & fast recovery, increasing awareness related to this technique in developing countries, and high preference from several medical practitioners. On November 19 2014, Hologic had launched NovaSure for the treatment of abnormal uterine bleeding and it’s was effectively accepted in the market by many surgeons, cost-efficiency & quick patient recovery has been key advantages assisting overall growth of NovaSure.
North America was identified as the largest endometrial ablation market in the year 2017 attributing to the overwork & sedentary lifestyle in women that assists prevalence of abnormal uterine bleeding and increasing awareness related to uterine bleeding & complexities associated with post-endometrial ablation surgeries. The Asia Pacific will maintain its dominance throughout the forecast period from 2018 to 2026 due to key driving factors such as increasing accessibility & availability of novel endometrial ablation devices and rising public awareness related to abnormal uterine bleeding and other complexities.
Market Competition Assessment:
The growth of endometrial ablation is at a significant pace and key companies operating in this market are focusing on the development of safe & efficient endometrial ablation devices. The major market players in this market are Boston Scientific Corporation, Olympus Corporation, Hologic Corporation, Smith & Nephew plc, Minerva Surgical, Inc., KARL STORZ GmbH & Co. KG, The Cooper Companies, Inc., Medtronic plc, Richard Wolf GmbH, Ethicon, Inc., AngioDynamics Inc. among others.
Key Market Movements:
- Increasing demand for minimally invasive endometrial ablation is expected to assist the future market growth
- Mounting prevalence of gynecological disorders is also assisting the awareness related to availability of treatments
- Technologically endometrial ablation devices are developing focusing specifically on the efficiency and swift recovery
- A few recalls related with endometrial ablation devices has been one of the key restraints restricting the market growth